Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for post-anesthesia shivering after cesarean section
ChiCTR1900023431Phase 4Completed
- Sponsor
- Shenzhen Maternal and Child Health Hospital
- Start
- Jun 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and dexmedetomidine in postanesthetic shivering (PAS) (3 arms), sponsored by Shenzhen Maternal and Child Health Hospital. Primary endpoint: Time to significant reduction in shivering. Started Jun 2017; status: completed.
02
Drugs
nalbuphinedexmedetomidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on ChiCTR1900023431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023431.